Participants
cancers
BRAIN TUMORS, TESTICULAR CANCER, CANCERS, LYMPHOMA
All young adults (18‐39 years) diagnosed with selected cancers (breast, cervical, ovarian, testicular cancer, brain tumors, and lymphoma) during a period of 18 months were identified in national quality registries and invited to participate in the Fex‐Can Cohort study approximately 1.5 years following diagnosis.Among those invited to the intervention (Flow diagram of study participants. RCT, randomized controlled trial.